Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2001
05/17/2001WO2001005425A3 Combined preparations comprising daunorubicin derivatives and her2 antibodies
05/17/2001WO2001004157A3 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS
05/17/2001WO2000077166A3 Gene expression modulated in gastrointestinal inflammation
05/17/2001WO2000071710A3 Expression products of genes involved in diseases related to cholesterol metabolism
05/17/2001WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
05/17/2001WO2000030671A9 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
05/17/2001WO1999038972A9 Human genes and gene expression products ii
05/17/2001US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes
05/17/2001DE10019473A1 Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden Polypeptide tag's for the detection and purification of polypeptides
05/17/2001CA2428827A1 Human vanilloid receptor gene
05/17/2001CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer
05/17/2001CA2390510A1 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders
05/17/2001CA2390504A1 Cytochrome p450 oxygenases and their uses
05/17/2001CA2390438A1 19 human secreted proteins
05/17/2001CA2390421A1 24 human secreted proteins
05/17/2001CA2390412A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
05/17/2001CA2390374A1 Diagnosis and treatment of malignant neoplasms
05/17/2001CA2389841A1 Novel nucleic acid molecules encoding cyclised amino acid sequences
05/17/2001CA2389724A1 28 human secreted proteins
05/17/2001CA2389722A1 15 human secreted proteins
05/17/2001CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/17/2001CA2389386A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents
05/17/2001CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies
05/17/2001CA2389326A1 35 human secreted proteins
05/17/2001CA2389305A1 28 human secreted proteins
05/17/2001CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof
05/17/2001CA2388914A1 15 human secreted proteins
05/17/2001CA2388912A1 6 human secreted proteins
05/17/2001CA2388829A1 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r2
05/17/2001CA2388019A1 24 human secreted proteins
05/17/2001CA2388008A1 29 human secreted proteins
05/17/2001CA2387964A1 22 human secreted proteins
05/17/2001CA2387959A1 21 human secreted proteins
05/17/2001CA2386866A1 Tumor suppressor molecules and methods of use
05/17/2001CA2359955A1 Human vanilloid receptor gene
05/17/2001CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances
05/16/2001EP1099757A1 Process for the determination of CTp11 and for determining whether a tumor sample has metatastic potential
05/16/2001EP1099116A1 Method for detecting central nervous system tissue (brain, spinal cord) in products, especially in heated meat products, and a test kit therefor
05/16/2001EP1098985A1 Genes of the dead box protein family, their expression products and use
05/16/2001EP1098981A1 A mutant human hepatitis b viral strain and uses thereof
05/16/2001EP1098979A2 Fap alpha-specific antibody with improved producibility
05/16/2001EP1098978A1 Gbs toxin receptor
05/16/2001EP1098975A1 Orphan cytokine receptor
05/16/2001EP1098973A1 Human lcb kinase 1
05/16/2001EP1098972A1 Protein similar to neuroendocrine-specific protein, and encoding cdna
05/16/2001EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors
05/16/2001EP1098962A2 Diacylglycerol acyl transferase proteins
05/16/2001EP1098909A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction
05/16/2001EP1098908A2 Anti-ccr2 antibodies and methods of use therefor
05/16/2001EP1098665A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
05/16/2001EP1098658A1 Engineered proteins for analyte sensing
05/16/2001EP1011328A4 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
05/16/2001EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
05/16/2001CN1295668A Methods and compositions for diagnosis of hepatoma
05/16/2001CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein
05/16/2001CN1295482A Antagonists of the inflammatory mediator oncostatin M (OSM)
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1065876C Coded protein specific antibody having cytoskeleton gene
05/16/2001CA2324168A1 Antibody specific to interleukin 18 precursor
05/15/2001US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein
05/15/2001US6232459 Synaptojanin isoform
05/15/2001US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders
05/15/2001US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor
05/15/2001US6232449 Persephin and related growth factors
05/15/2001US6232448 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase
05/15/2001US6232447 Antibody immunoreactive with a human cytokine designated LERK-6
05/15/2001US6232446 Antibody to human tumor necrosis factor (tnf) binding protein which binds to extracellular domain of the c-terminal cysteine loop of the receptor; inhibit cytotoxic effect but not its binding to the receptor
05/15/2001US6232444 Conserved anti-DNA antibody idiotype associated with nephritis in murine and human lupus
05/15/2001US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders
05/15/2001US6232441 PIGR-1, a member of immunoglobulin gene superfamily
05/15/2001US6232437 Detection of normal and abnormally phosphorylation in brain extracts and non-concentrated cerebrospinal fluid; immunological complex specific and preferential; use in diagnosis of alzheimer's disease
05/15/2001US6232292 3-dehydroquinate synthase
05/15/2001US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors
05/15/2001US6232123 Immunoglobulin for the diagnosis and treatment of tumors, leukemias, lymphomas and autoimmune diseases
05/15/2001US6232108 Prenylcysteine carboxyl methyltransferase, DNA encoding same, and a method of screening for inhibitors thereof
05/15/2001US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection
05/15/2001US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development
05/15/2001US6232096 Flea serine protease nucleic acid molecules and uses thereof
05/15/2001US6232086 Method for detecting cancer cells
05/15/2001US6232084 Competitive binding
05/15/2001US6232082 Vaccines
05/15/2001US6232081 Complexing with slimb protein
05/15/2001US6232080 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
05/15/2001US6232077 Genetic engineering and expression; cancer diagnosis
05/15/2001US6231864 Strategically modified hepatitis B core proteins and their derivatives
05/15/2001US6231861 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
05/15/2001US6231857 Antibodies to S. mutans and uses thereof
05/15/2001US6231856 Methods and compositions for treatment of autoimmune diseases
05/15/2001US6231855 Side effect reduction
05/15/2001CA2183268C Bispecific molecules having clinical utilities
05/15/2001CA2158054C Conjugates of proteins and bifunctional ligands
05/15/2001CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2
05/15/2001CA1341227C Human transforming growth factor alpha
05/10/2001WO2001033221A1 Axor35, a g-protein coupled receptor
05/10/2001WO2001033218A1 Method for identifying active anti-apoptosis compounds
05/10/2001WO2001032927A2 Tissue specific genes of diagnostic import
05/10/2001WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
05/10/2001WO2001032910A2 27 human secreted proteins
05/10/2001WO2001032908A1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
05/10/2001WO2001032893A1 Recombinant therapeutic fusion proteins